Skip to content
healthcare.dev

SILDENAFIL CITRATE

NDC 76420-613, SILDENAFIL CITRATE, tablet, from Asclemed USA, Inc..

Product NDC
76420-613
Status
Listed
Labeler
Asclemed USA, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091479
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76420-613 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SILDENAFIL CITRATE20 mg/1

Pharmacologic classes

Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]

Package NDCNDC-11Package
76420-613-307642006133030 TABLET in 1 BOTTLE (76420-613-30)
76420-613-607642006136060 TABLET in 1 BOTTLE (76420-613-60)
76420-613-907642006139090 TABLET in 1 BOTTLE (76420-613-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/49a95b25-08b3-4cfe-a60b-c5132c280be2

Use it

Look up 76420-613 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76420-613 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76420-613. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.